These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17404263

  • 21. Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
    Torphy TJ, Zhou HL, Foley JJ, Sarau HM, Manning CD, Barnette MS.
    J Biol Chem; 1995 Oct 06; 270(40):23598-604. PubMed ID: 7559525
    [Abstract] [Full Text] [Related]

  • 22. Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.
    Mika D, Bobin P, Pomérance M, Lechêne P, Westenbroek RE, Catterall WA, Vandecasteele G, Leroy J, Fischmeister R.
    Cardiovasc Res; 2013 Nov 01; 100(2):336-46. PubMed ID: 23933582
    [Abstract] [Full Text] [Related]

  • 23. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin SL.
    Mol Pharmacol; 1995 Jun 01; 47(6):1164-71. PubMed ID: 7603456
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A.
    Clin Cancer Res; 2002 Feb 01; 8(2):589-95. PubMed ID: 11839681
    [Abstract] [Full Text] [Related]

  • 25. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
    Levallet G, Levallet J, Bouraïma-Lelong H, Bonnamy PJ.
    Biol Reprod; 2007 May 01; 76(5):794-803. PubMed ID: 17215491
    [Abstract] [Full Text] [Related]

  • 26. TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.
    Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, Ruppelt A, Mustelin T, Zaccolo M, Houslay M, Taskén K.
    J Immunol; 2004 Oct 15; 173(8):4847-58. PubMed ID: 15470025
    [Abstract] [Full Text] [Related]

  • 27. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
    Heystek HC, Thierry AC, Soulard P, Moulon C.
    Int Immunol; 2003 Jul 15; 15(7):827-35. PubMed ID: 12807821
    [Abstract] [Full Text] [Related]

  • 28. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
    Kostic MM, Erdogan S, Rena G, Borchert G, Hoch B, Bartel S, Scotland G, Huston E, Houslay MD, Krause EG.
    J Mol Cell Cardiol; 1997 Nov 15; 29(11):3135-46. PubMed ID: 9405187
    [Abstract] [Full Text] [Related]

  • 29. CD3- and CD28-dependent induction of PDE7 required for T cell activation.
    Li L, Yee C, Beavo JA.
    Science; 1999 Feb 05; 283(5403):848-51. PubMed ID: 9933169
    [Abstract] [Full Text] [Related]

  • 30. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ, Spink KG, Ren X, Afzal S, Banner KH, Wharton J.
    Respir Res; 2006 Jan 19; 7(1):9. PubMed ID: 16423283
    [Abstract] [Full Text] [Related]

  • 31. siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.
    Cheng H, Wu Z, He X, Liu Q, Jia H, Di Y, Ji Q.
    Exp Ther Med; 2016 Oct 19; 12(4):2257-2264. PubMed ID: 27698721
    [Abstract] [Full Text] [Related]

  • 32. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.
    Lynch MJ, Baillie GS, Mohamed A, Li X, Maisonneuve C, Klussmann E, van Heeke G, Houslay MD.
    J Biol Chem; 2005 Sep 30; 280(39):33178-89. PubMed ID: 16030021
    [Abstract] [Full Text] [Related]

  • 33. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.
    Pérez-Torres S, Miró X, Palacios JM, Cortés R, Puigdoménech P, Mengod G.
    J Chem Neuroanat; 2000 Dec 30; 20(3-4):349-74. PubMed ID: 11207431
    [Abstract] [Full Text] [Related]

  • 34. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.
    Jin SL, Conti M.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7628-33. PubMed ID: 12032334
    [Abstract] [Full Text] [Related]

  • 35. PDE4D plays a critical role in the control of airway smooth muscle contraction.
    Méhats C, Jin SL, Wahlstrom J, Law E, Umetsu DT, Conti M.
    FASEB J; 2003 Oct 28; 17(13):1831-41. PubMed ID: 14519662
    [Abstract] [Full Text] [Related]

  • 36. DMSO-treated HL60 cells: a model of neutrophil-like cells mainly expressing PDE4B subtype.
    Jacob C, Leport M, Szilagyi C, Allen JM, Bertrand C, Lagente V.
    Int Immunopharmacol; 2002 Nov 28; 2(12):1647-56. PubMed ID: 12469939
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
    Xu M, Yu X, Meng X, Huang S, Zhang Y, Zhang A, Jia Z.
    Am J Physiol Renal Physiol; 2020 Mar 01; 318(3):F576-F588. PubMed ID: 31961716
    [Abstract] [Full Text] [Related]

  • 38. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S, Dong H, Kim EJ, Weintraub L, Epstein PM, Lerner A.
    Biochem Pharmacol; 2005 Feb 01; 69(3):473-83. PubMed ID: 15652238
    [Abstract] [Full Text] [Related]

  • 39. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.
    Ma D, Wu P, Egan RW, Billah MM, Wang P.
    Mol Pharmacol; 1999 Jan 01; 55(1):50-7. PubMed ID: 9882697
    [Abstract] [Full Text] [Related]

  • 40. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
    Bartsch O, Bartlick B, Ivell R.
    J Clin Endocrinol Metab; 2004 Jan 01; 89(1):324-34. PubMed ID: 14715868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.